speb/financial-data huggingface dataset:
CTRN income_statement (quarterly, 2025-07-31) — Net Income: 3818000.00
CTRN income_statement (quarterly, 2025-07-31) — Net Income Common Stockholders: 3818000.00
CTRN income_statement (quarterly, 2025-07-31) — Net Income Continuous Operations: 3818000.00
CTRN income_statement (quarterly, 2025-07-31) — Net Income From Continuing And Discontinued Operation: 3818000.00
CTRN income_statement (quarterly, 2025-07-31) — Net Income From Continuing Operation Net Minority Interest: 3818000.00
CTRN cash_flow (quarterly, 2025-07-31) — Net Income From Continuing Operations: 3818000.00
CTRN income_statement (quarterly, 2025-07-31) — Net Income Including Noncontrolling Interests: 3818000.00
CTRN income_statement (quarterly, 2025-07-31) — Net Interest Income: 301000.00
CTRN income_statement (quarterly, 2025-07-31) — Net Non Operating Interest Income Expense: 301000.00
CTRN cash_flow (quarterly, 2025-07-31) — Net Other Financing Charges: -619000.00
CTRN balance_sheet (quarterly, 2025-07-31) — Net PPE: 266942000.00
CTRN cash_flow (quarterly, 2025-07-31) — Net PPE Purchase And Sale: 5605000.00
CTRN balance_sheet (quarterly, 2025-07-31) — Net Tangible Assets: 113240000.00
CTRN balance_sheet (quarterly, 2025-07-31) — Non Current Deferred Liabilities: 142000.00
CTRN balance_sheet (quarterly, 2025-07-31) — Non Current Deferred Taxes Liabilities: 142000.00
CTRN income_statement (quarterly, 2025-07-31) — Normalized EBITDA: -2243000.00
CTRN income_statement (quarterly, 2025-07-31) — Normalized Income: -6879000.00
CTRN cash_flow (quarterly, 2025-07-31) — Operating Cash Flow: 3855000.00
CTRN income_statement (quarterly, 2025-07-31) — Operating Income: -7180000.00
CTRN income_statement (quarterly, 2025-07-31) — Operating Revenue: 190750000.00
CTRN balance_sheet (quarterly, 2025-07-31) — Ordinary Shares Number: 8305912.00
CTRN balance_sheet (quarterly, 2025-07-31) — Other Current Assets: 19635000.00
CTRN income_statement (quarterly, 2025-07-31) — Other Income Expense: 10697000.00
CTRN cash_flow (quarterly, 2025-07-31) — Other Non Cash Items: 12088000.00
CTRN balance_sheet (quarterly, 2025-07-31) — Other Non Current Assets: 1262000.00
CTRN balance_sheet (quarterly, 2025-07-31) — Other Non Current Liabilities: 2505000.00
CTRN balance_sheet (quarterly, 2025-07-31) — Other Properties: 560545000.00
CTRN balance_sheet (quarterly, 2025-07-31) — Payables: 96245000.00
CTRN balance_sheet (quarterly, 2025-07-31) — Payables And Accrued Expenses: 113530000.00
CTRN balance_sheet (quarterly, 2025-07-31) — Pensionand Other Post Retirement Benefit Plans Current: 9172000.00
CTRN income_statement (quarterly, 2025-07-31) — Pretax Income: 3818000.00
CTRN cash_flow (quarterly, 2025-07-31) — Purchase Of PPE: -5601000.00
CTRN balance_sheet (quarterly, 2025-07-31) — Receivables: 1606000.00
CTRN income_statement (quarterly, 2025-07-31) — Reconciled Cost Of Revenue: 114477000.00
CTRN income_statement (quarterly, 2025-07-31) — Reconciled Depreciation: 4548000.00
CTRN cash_flow (quarterly, 2025-07-31) — Repurchase Of Capital Stock: 0.00
CTRN balance_sheet (quarterly, 2025-07-31) — Retained Earnings: 280590000.00
CTRN income_statement (quarterly, 2025-07-31) — Selling General And Administration: 78905000.00
CTRN balance_sheet (quarterly, 2025-07-31) — Share Issued: 16505718.00
CTRN income_statement (quarterly, 2025-07-31) — Special Income Charges: 10697000.00
CTRN cash_flow (quarterly, 2025-07-31) — Stock Based Compensation: 1483000.00
CTRN balance_sheet (quarterly, 2025-07-31) — Stockholders Equity: 113240000.00
CTRN balance_sheet (quarterly, 2025-07-31) — Tangible Book Value: 113240000.00
CTRN income_statement (quarterly, 2025-07-31) — Tax Effect Of Unusual Items: 0.00
CTRN income_statement (quarterly, 2025-07-31) — Tax Provision: 0.00
CTRN income_statement (quarterly, 2025-07-31) — Tax Rate For Calcs: 0.00
CTRN balance_sheet (quarterly, 2025-07-31) — Taxes Receivable: 1606000.00
CTRN balance_sheet (quarterly, 2025-07-31) — Total Assets: 457408000.00
CTRN balance_sheet (quarterly, 2025-07-31) — Total Capitalization: 113240000.00
CTRN balance_sheet (quarterly, 2025-07-31) — Total Debt: 217489000.00
CTRN balance_sheet (quarterly, 2025-07-31) — Total Equity Gross Minority Interest: 113240000.00
CTRN income_statement (quarterly, 2025-07-31) — Total Expenses: 197930000.00
CTRN balance_sheet (quarterly, 2025-07-31) — Total Liabilities Net Minority Interest: 344168000.00
CTRN balance_sheet (quarterly, 2025-07-31) — Total Non Current Assets: 268204000.00
CTRN balance_sheet (quarterly, 2025-07-31) — Total Non Current Liabilities Net Minority Interest: 176792000.00
CTRN income_statement (quarterly, 2025-07-31) — Total Operating Income As Reported: 3517000.00
CTRN income_statement (quarterly, 2025-07-31) — Total Unusual Items: 10697000.00
CTRN income_statement (quarterly, 2025-07-31) — Total Unusual Items Excluding Goodwill: 10697000.00
CTRN balance_sheet (quarterly, 2025-07-31) — Treasury Shares Number: 8199806.00
CTRN balance_sheet (quarterly, 2025-07-31) — Treasury Stock: 277303000.00
CTRN balance_sheet (quarterly, 2025-07-31) — Working Capital: 21828000.00
CTRN income_statement (quarterly, 2025-10-31) — +Operating Expense: 83973000.00
CTRN income_statement (quarterly, 2025-10-31) — +Total Revenue: 197091000.00
CTRN balance_sheet (quarterly, 2025-10-31) — Accounts Payable: 97986000.00
CTRN balance_sheet (quarterly, 2025-10-31) — Accumulated Depreciation: -298162000.00
CTRN balance_sheet (quarterly, 2025-10-31) — Additional Paid In Capital: 111275000.00
CTRN cash_flow (quarterly, 2025-10-31) — Asset Impairment Charge: 0.00
CTRN income_statement (quarterly, 2025-10-31) — Basic Average Shares: 8050000.00
CTRN income_statement (quarterly, 2025-10-31) — Basic EPS: -0.86
CTRN cash_flow (quarterly, 2025-10-31) — Beginning Cash Position: 50397000.00
CTRN cash_flow (quarterly, 2025-10-31) — Capital Expenditure: -7814000.00
CTRN balance_sheet (quarterly, 2025-10-31) — Capital Lease Obligations: 218038000.00
CTRN balance_sheet (quarterly, 2025-10-31) — Capital Stock: 162000.00
CTRN balance_sheet (quarterly, 2025-10-31) — Cash And Cash Equivalents: 51098000.00
CTRN balance_sheet (quarterly, 2025-10-31) — Cash Cash Equivalents And Short Term Investments: 51098000.00
CTRN cash_flow (quarterly, 2025-10-31) — Cash Flow From Continuing Financing Activities: -66000.00
CTRN cash_flow (quarterly, 2025-10-31) — Cash Flow From Continuing Investing Activities: -7814000.00
CTRN cash_flow (quarterly, 2025-10-31) — Cash Flow From Continuing Operating Activities: 8581000.00
CTRN cash_flow (quarterly, 2025-10-31) — Change In Account Payable: 1995000.00
CTRN cash_flow (quarterly, 2025-10-31) — Change In Accrued Expense: -1843000.00
CTRN cash_flow (quarterly, 2025-10-31) — Change In Inventory: -5970000.00
CTRN cash_flow (quarterly, 2025-10-31) — Change In Other Current Assets: -558000.00
CTRN cash_flow (quarterly, 2025-10-31) — Change In Other Working Capital: 232000.00
CTRN cash_flow (quarterly, 2025-10-31) — Change In Payable: 1995000.00
CTRN cash_flow (quarterly, 2025-10-31) — Change In Payables And Accrued Expense: 152000.00
CTRN cash_flow (quarterly, 2025-10-31) — Change In Prepaid Assets: 4229000.00
CTRN cash_flow (quarterly, 2025-10-31) — Change In Working Capital: -1915000.00
CTRN cash_flow (quarterly, 2025-10-31) — Changes In Cash: 701000.00
CTRN balance_sheet (quarterly, 2025-10-31) — Common Stock: 162000.00
CTRN balance_sheet (quarterly, 2025-10-31) — Common Stock Equity: 107830000.00
CTRN cash_flow (quarterly, 2025-10-31) — Common Stock Payments: 0.00
CTRN income_statement (quarterly, 2025-10-31) — Cost Of Revenue: 120462000.00
CTRN balance_sheet (quarterly, 2025-10-31) — Current Accrued Expenses: 21622000.00
CTRN balance_sheet (quarterly, 2025-10-31) — Current Assets: 192092000.00
CTRN balance_sheet (quarterly, 2025-10-31) — Current Capital Lease Obligation: 43585000.00
CTRN balance_sheet (quarterly, 2025-10-31) — Current Debt And Capital Lease Obligation: 43585000.00
CTRN balance_sheet (quarterly, 2025-10-31) — Current Deferred Liabilities: 2008000.00
CTRN balance_sheet (quarterly, 2025-10-31) — Current Deferred Revenue: 2008000.00
CTRN balance_sheet (quarterly, 2025-10-31) — Current Liabilities: 179847000.00
CTRN cash_flow (quarterly, 2025-10-31) — Deferred Income Tax: 0.00
CTRN cash_flow (quarterly, 2025-10-31) — Deferred Tax: 0.00
CTRN cash_flow (quarterly, 2025-10-31) — Depreciation: 4627000.00
CTRN cash_flow (quarterly, 2025-10-31) — Depreciation Amortization Depletion: 4627000.00
CTRN income_statement (quarterly, 2025-10-31) — Depreciation Amortization Depletion Income Statement: 4627000.00
CTRN cash_flow (quarterly, 2025-10-31) — Depreciation And Amortization: 4627000.00
CTRN income_statement (quarterly, 2025-10-31) — Depreciation And Amortization In Income Statement: 4627000.00
CTRN income_statement (quarterly, 2025-10-31) — Depreciation Income Statement: 4627000.00
CTRN income_statement (quarterly, 2025-10-31) — Diluted Average Shares: 8050000.00
CTRN income_statement (quarterly, 2025-10-31) — Diluted EPS: -0.86
CTRN income_statement (quarterly, 2025-10-31) — Diluted NI Availto Com Stockholders: -6894000.00
CTRN income_statement (quarterly, 2025-10-31) — EBIT: -6803000.00
CTRN income_statement (quarterly, 2025-10-31) — EBITDA: -2176000.00
CTRN cash_flow (quarterly, 2025-10-31) — End Cash Position: 51098000.00
CTRN cash_flow (quarterly, 2025-10-31) — Financing Cash Flow: -66000.00
CTRN cash_flow (quarterly, 2025-10-31) — Free Cash Flow: 767000.00
CTRN cash_flow (quarterly, 2025-10-31) — Gain Loss On Sale Of PPE: -134000.00
CTRN balance_sheet (quarterly, 2025-10-31) — Gross PPE: 568510000.00
CTRN income_statement (quarterly, 2025-10-31) — Gross Profit: 76629000.00
CTRN income_statement (quarterly, 2025-10-31) — Interest Expense: 91000.00
CTRN income_statement (quarterly, 2025-10-31) — Interest Expense Non Operating: 91000.00
CTRN income_statement (quarterly, 2025-10-31) — Interest Income: 541000.00
CTRN income_statement (quarterly, 2025-10-31) — Interest Income Non Operating: 541000.00
CTRN cash_flow (quarterly, 2025-10-31) — Interest Paid Supplemental Data: 57000.00
CTRN balance_sheet (quarterly, 2025-10-31) — Inventory: 123536000.00
CTRN balance_sheet (quarterly, 2025-10-31) — Invested Capital: 107830000.00
CTRN cash_flow (quarterly, 2025-10-31) — Investing Cash Flow: -7814000.00
CTRN balance_sheet (quarterly, 2025-10-31) — Long Term Capital Lease Obligation: 174453000.00
CTRN balance_sheet (quarterly, 2025-10-31) — Long Term Debt And Capital Lease Obligation: 174453000.00
CTRN cash_flow (quarterly, 2025-10-31) — Net Common Stock Issuance: 0.00
CTRN income_statement (quarterly, 2025-10-31) — Net Income: -6894000.00
CTRN income_statement (quarterly, 2025-10-31) — Net Income Common Stockholders: -6894000.00
CTRN income_statement (quarterly, 2025-10-31) — Net Income Continuous Operations: -6894000.00
CTRN income_statement (quarterly, 2025-10-31) — Net Income From Continuing And Discontinued Operation: -6894000.00
CTRN income_statement (quarterly, 2025-10-31) — Net Income From Continuing Operation Net Minority Interest: -6894000.00
CTRN cash_flow (quarterly, 2025-10-31) — Net Income From Continuing Operations: -6894000.00
CTRN income_statement (quarterly, 2025-10-31) — Net Income Including Noncontrolling Interests: -6894000.00
CTRN income_statement (quarterly, 2025-10-31) — Net Interest Income: 450000.00
CTRN income_statement (quarterly, 2025-10-31) — Net Non Operating Interest Income Expense: 450000.00
CTRN cash_flow (quarterly, 2025-10-31) — Net Other Financing Charges: -66000.00
CTRN balance_sheet (quarterly, 2025-10-31) — Net PPE: 270348000.00
CTRN cash_flow (quarterly, 2025-10-31) — Net PPE Purchase And Sale: -7814000.00
CTRN balance_sheet (quarterly, 2025-10-31) — Net Tangible Assets: 107830000.00
CTRN balance_sheet (quarterly, 2025-10-31) — Non Current Deferred Liabilities: 142000.00
CTRN balance_sheet (quarterly, 2025-10-31) — Non Current Deferred Taxes Liabilities: 142000.00
CTRN income_statement (quarterly, 2025-10-31) — Normalized EBITDA: -2176000.00
CTRN income_statement (quarterly, 2025-10-31) — Normalized Income: -6894000.00
CTRN cash_flow (quarterly, 2025-10-31) — Operating Cash Flow: 8581000.00
CTRN cash_flow (quarterly, 2025-10-31) — Operating Gains Losses: -134000.00
CTRN income_statement (quarterly, 2025-10-31) — Operating Income: -7344000.00
CTRN income_statement (quarterly, 2025-10-31) — Operating Revenue: 197091000.00
CTRN balance_sheet (quarterly, 2025-10-31) — Ordinary Shares Number: 8300528.00
CTRN balance_sheet (quarterly, 2025-10-31) — Other Current Assets: 16084000.00
CTRN cash_flow (quarterly, 2025-10-31) — Other Non Cash Items: 11347000.00
CTRN balance_sheet (quarterly, 2025-10-31) — Other Non Current Assets: 1820000.00
CTRN balance_sheet (quarterly, 2025-10-31) — Other Non Current Liabilities: 1988000.00
CTRN balance_sheet (quarterly, 2025-10-31) — Other Properties: 568510000.00
CTRN balance_sheet (quarterly, 2025-10-31) — Payables: 97986000.00
CTRN balance_sheet (quarterly, 2025-10-31) — Payables And Accrued Expenses: 119608000.00
CTRN balance_sheet (quarterly, 2025-10-31) — Pensionand Other Post Retirement Benefit Plans Current: 14646000.00
CTRN income_statement (quarterly, 2025-10-31) — Pretax Income: -6894000.00
CTRN cash_flow (quarterly, 2025-10-31) — Purchase Of PPE: -7814000.00
CTRN balance_sheet (quarterly, 2025-10-31) — Receivables: 1374000.00
CTRN income_statement (quarterly, 2025-10-31) — Reconciled Cost Of Revenue: 120462000.00
CTRN income_statement (quarterly, 2025-10-31) — Reconciled Depreciation: 4627000.00
CTRN cash_flow (quarterly, 2025-10-31) — Repurchase Of Capital Stock: 0.00
CTRN balance_sheet (quarterly, 2025-10-31) — Retained Earnings: 273696000.00
CTRN cash_flow (quarterly, 2025-10-31) — Sale Of PPE: 0.00
CTRN income_statement (quarterly, 2025-10-31) — Selling General And Administration: 79346000.00
CTRN balance_sheet (quarterly, 2025-10-31) — Share Issued: 16500334.00
CTRN income_statement (quarterly, 2025-10-31) — Special Income Charges: 0.00
CTRN cash_flow (quarterly, 2025-10-31) — Stock Based Compensation: 1550000.00
CTRN balance_sheet (quarterly, 2025-10-31) — Stockholders Equity: 107830000.00
CTRN balance_sheet (quarterly, 2025-10-31) — Tangible Book Value: 107830000.00
CTRN income_statement (quarterly, 2025-10-31) — Tax Effect Of Unusual Items: 0.00
CTRN income_statement (quarterly, 2025-10-31) — Tax Provision: 0.00
CTRN income_statement (quarterly, 2025-10-31) — Tax Rate For Calcs: 0.00
CTRN balance_sheet (quarterly, 2025-10-31) — Taxes Receivable: 1374000.00
CTRN balance_sheet (quarterly, 2025-10-31) — Total Assets: 464260000.00
CTRN balance_sheet (quarterly, 2025-10-31) — Total Capitalization: 107830000.00
CTRN balance_sheet (quarterly, 2025-10-31) — Total Debt: 218038000.00
CTRN balance_sheet (quarterly, 2025-10-31) — Total Equity Gross Minority Interest: 107830000.00
CTRN income_statement (quarterly, 2025-10-31) — Total Expenses: 204435000.00
CTRN balance_sheet (quarterly, 2025-10-31) — Total Liabilities Net Minority Interest: 356430000.00
CTRN balance_sheet (quarterly, 2025-10-31) — Total Non Current Assets: 272168000.00
CTRN balance_sheet (quarterly, 2025-10-31) — Total Non Current Liabilities Net Minority Interest: 176583000.00
CTRN income_statement (quarterly, 2025-10-31) — Total Operating Income As Reported: -7344000.00
CTRN income_statement (quarterly, 2025-10-31) — Total Unusual Items: 0.00
CTRN income_statement (quarterly, 2025-10-31) — Total Unusual Items Excluding Goodwill: 0.00
CTRN balance_sheet (quarterly, 2025-10-31) — Treasury Shares Number: 8199806.00
CTRN balance_sheet (quarterly, 2025-10-31) — Treasury Stock: 277303000.00
CTRN balance_sheet (quarterly, 2025-10-31) — Working Capital: 12245000.00
CTRN income_statement (quarterly, 2025-10-31) — Write Off: 0.00
CTRN income_statement (annual, 2026-01-31) — +Operating Expense: 331653000.00
CTRN income_statement (quarterly, 2026-01-31) — +Operating Expense: 84970000.00
CTRN income_statement (annual, 2026-01-31) — +Total Revenue: 819962000.00
CTRN income_statement (quarterly, 2026-01-31) — +Total Revenue: 230393000.00
CTRN balance_sheet (annual, 2026-01-31) — Accounts Payable: 100693000.00
CTRN balance_sheet (quarterly, 2026-01-31) — Accounts Payable: 100693000.00
CTRN balance_sheet (annual, 2026-01-31) — Accumulated Depreciation: -301921000.00
CTRN balance_sheet (quarterly, 2026-01-31) — Accumulated Depreciation: -301921000.00
CTRN balance_sheet (annual, 2026-01-31) — Additional Paid In Capital: 112352000.00
CTRN balance_sheet (quarterly, 2026-01-31) — Additional Paid In Capital: 112352000.00
CTRN cash_flow (annual, 2026-01-31) — Asset Impairment Charge: 579000.00
CTRN cash_flow (quarterly, 2026-01-31) — Asset Impairment Charge: 252000.00
CTRN income_statement (annual, 2026-01-31) — Basic Average Shares: 8057000.00
CTRN income_statement (quarterly, 2026-01-31) — Basic Average Shares: 8113000.00
CTRN income_statement (annual, 2026-01-31) — Basic EPS: 0.65
CTRN income_statement (quarterly, 2026-01-31) — Basic EPS: 0.91
CTRN cash_flow (annual, 2026-01-31) — Beginning Cash Position: 61085000.00
CTRN cash_flow (quarterly, 2026-01-31) — Beginning Cash Position: 51098000.00
CTRN balance_sheet (annual, 2026-01-31) — Buildings And Improvements: 0.00
CTRN balance_sheet (quarterly, 2026-01-31) — Buildings And Improvements: 0.00
CTRN cash_flow (annual, 2026-01-31) — Capital Expenditure: -20330000.00
CTRN cash_flow (quarterly, 2026-01-31) — Capital Expenditure: -4811000.00
CTRN balance_sheet (annual, 2026-01-31) — Capital Lease Obligations: 223318000.00
CTRN balance_sheet (quarterly, 2026-01-31) — Capital Lease Obligations: 223318000.00
CTRN balance_sheet (annual, 2026-01-31) — Capital Stock: 163000.00
CTRN balance_sheet (quarterly, 2026-01-31) — Capital Stock: 163000.00
CTRN balance_sheet (annual, 2026-01-31) — Cash And Cash Equivalents: 66092000.00
CTRN balance_sheet (quarterly, 2026-01-31) — Cash And Cash Equivalents: 66092000.00
CTRN balance_sheet (annual, 2026-01-31) — Cash Cash Equivalents And Short Term Investments: 66092000.00
CTRN balance_sheet (quarterly, 2026-01-31) — Cash Cash Equivalents And Short Term Investments: 66092000.00
CTRN cash_flow (annual, 2026-01-31) — Cash Flow From Continuing Financing Activities: -7453000.00
CTRN cash_flow (quarterly, 2026-01-31) — Cash Flow From Continuing Financing Activities: -312000.00
CTRN cash_flow (annual, 2026-01-31) — Cash Flow From Continuing Investing Activities: -8494000.00
CTRN cash_flow (quarterly, 2026-01-31) — Cash Flow From Continuing Investing Activities: -4181000.00
CTRN cash_flow (annual, 2026-01-31) — Cash Flow From Continuing Operating Activities: 20954000.00
CTRN cash_flow (quarterly, 2026-01-31) — Cash Flow From Continuing Operating Activities: 19487000.00
CTRN cash_flow (annual, 2026-01-31) — Change In Account Payable: -3305000.00
CTRN cash_flow (quarterly, 2026-01-31) — Change In Account Payable: 1825000.00
CTRN cash_flow (annual, 2026-01-31) — Change In Accrued Expense: -49567000.00
CTRN cash_flow (quarterly, 2026-01-31) — Change In Accrued Expense: -20118000.00
CTRN cash_flow (annual, 2026-01-31) — Change In Inventory: 9125000.00
CTRN cash_flow (quarterly, 2026-01-31) — Change In Inventory: 10021000.00
CTRN cash_flow (annual, 2026-01-31) — Change In Other Current Assets: -1118000.00
CTRN cash_flow (quarterly, 2026-01-31) — Change In Other Current Assets: -144000.00
CTRN cash_flow (annual, 2026-01-31) — Change In Other Working Capital: 1932000.00
CTRN cash_flow (quarterly, 2026-01-31) — Change In Other Working Capital: 187000.00
CTRN cash_flow (annual, 2026-01-31) — Change In Payable: -3305000.00
CTRN cash_flow (quarterly, 2026-01-31) — Change In Payable: 1825000.00
CTRN cash_flow (annual, 2026-01-31) — Change In Payables And Accrued Expense: -52872000.00
CTRN cash_flow (quarterly, 2026-01-31) — Change In Payables And Accrued Expense: -18293000.00
CTRN cash_flow (annual, 2026-01-31) — Change In Prepaid Assets: -2043000.00
CTRN cash_flow (quarterly, 2026-01-31) — Change In Prepaid Assets: 2205000.00
CTRN cash_flow (annual, 2026-01-31) — Change In Working Capital: -44976000.00
CTRN cash_flow (quarterly, 2026-01-31) — Change In Working Capital: -6024000.00
CTRN cash_flow (annual, 2026-01-31) — Changes In Cash: 5007000.00
CTRN cash_flow (quarterly, 2026-01-31) — Changes In Cash: 14994000.00
CTRN balance_sheet (annual, 2026-01-31) — Common Stock: 163000.00
CTRN balance_sheet (quarterly, 2026-01-31) — Common Stock: 163000.00
CTRN balance_sheet (annual, 2026-01-31) — Common Stock Equity: 116320000.00
CTRN balance_sheet (quarterly, 2026-01-31) — Common Stock Equity: 116320000.00
CTRN cash_flow (annual, 2026-01-31) — Common Stock Payments: -6315000.00
CTRN cash_flow (quarterly, 2026-01-31) — Common Stock Payments: 0.00
CTRN balance_sheet (annual, 2026-01-31) — Construction In Progress: 856000.00
CTRN balance_sheet (quarterly, 2026-01-31) — Construction In Progress: 856000.00
CTRN income_statement (annual, 2026-01-31) — Cost Of Revenue: 495320000.00
CTRN income_statement (quarterly, 2026-01-31) — Cost Of Revenue: 138463000.00
CTRN balance_sheet (annual, 2026-01-31) — Current Accrued Expenses: 15134000.00
CTRN balance_sheet (quarterly, 2026-01-31) — Current Accrued Expenses: 15134000.00
CTRN balance_sheet (annual, 2026-01-31) — Current Assets: 193048000.00
CTRN balance_sheet (quarterly, 2026-01-31) — Current Assets: 193048000.00
CTRN balance_sheet (annual, 2026-01-31) — Current Capital Lease Obligation: 44397000.00
CTRN balance_sheet (quarterly, 2026-01-31) — Current Capital Lease Obligation: 44397000.00
CTRN balance_sheet (annual, 2026-01-31) — Current Debt And Capital Lease Obligation: 44397000.00
CTRN balance_sheet (quarterly, 2026-01-31) — Current Debt And Capital Lease Obligation: 44397000.00
CTRN balance_sheet (annual, 2026-01-31) — Current Deferred Liabilities: 383000.00
CTRN balance_sheet (quarterly, 2026-01-31) — Current Deferred Liabilities: 383000.00
CTRN balance_sheet (annual, 2026-01-31) — Current Deferred Revenue: 383000.00
CTRN balance_sheet (quarterly, 2026-01-31) — Current Deferred Revenue: 383000.00
CTRN balance_sheet (annual, 2026-01-31) — Current Liabilities: 173407000.00
CTRN balance_sheet (quarterly, 2026-01-31) — Current Liabilities: 173407000.00
CTRN cash_flow (annual, 2026-01-31) — Deferred Income Tax: 102000.00
CTRN cash_flow (quarterly, 2026-01-31) — Deferred Income Tax: 102000.00
CTRN cash_flow (annual, 2026-01-31) — Deferred Tax: 102000.00
CTRN cash_flow (quarterly, 2026-01-31) — Deferred Tax: 102000.00
CTRN cash_flow (annual, 2026-01-31) — Depreciation: 18482000.00
CTRN cash_flow (quarterly, 2026-01-31) — Depreciation: 4937000.00
CTRN cash_flow (annual, 2026-01-31) — Depreciation Amortization Depletion: 18482000.00
CTRN cash_flow (quarterly, 2026-01-31) — Depreciation Amortization Depletion: 4937000.00
CTRN income_statement (annual, 2026-01-31) — Depreciation Amortization Depletion Income Statement: 18482000.00
CTRN income_statement (quarterly, 2026-01-31) — Depreciation Amortization Depletion Income Statement: 4937000.00
CTRN cash_flow (annual, 2026-01-31) — Depreciation And Amortization: 18482000.00
CTRN cash_flow (quarterly, 2026-01-31) — Depreciation And Amortization: 4937000.00
CTRN income_statement (annual, 2026-01-31) — Depreciation And Amortization In Income Statement: 18482000.00
CTRN income_statement (quarterly, 2026-01-31) — Depreciation And Amortization In Income Statement: 4937000.00
CTRN income_statement (annual, 2026-01-31) — Depreciation Income Statement: 18482000.00
CTRN income_statement (quarterly, 2026-01-31) — Depreciation Income Statement: 4937000.00
CTRN income_statement (annual, 2026-01-31) — Diluted Average Shares: 8300000.00
CTRN income_statement (quarterly, 2026-01-31) — Diluted Average Shares: 8411000.00
CTRN income_statement (annual, 2026-01-31) — Diluted EPS: 0.63
CTRN income_statement (quarterly, 2026-01-31) — Diluted EPS: 0.88
CTRN income_statement (annual, 2026-01-31) — Diluted NI Availto Com Stockholders: 5207000.00
CTRN income_statement (quarterly, 2026-01-31) — Diluted NI Availto Com Stockholders: 7412000.00
CTRN income_statement (annual, 2026-01-31) — EBIT: 5845000.00
CTRN income_statement (quarterly, 2026-01-31) — EBIT: 7795000.00
CTRN income_statement (annual, 2026-01-31) — EBITDA: 24327000.00
CTRN income_statement (quarterly, 2026-01-31) — EBITDA: 12732000.00
CTRN cash_flow (annual, 2026-01-31) — End Cash Position: 66092000.00
CTRN cash_flow (quarterly, 2026-01-31) — End Cash Position: 66092000.00
CTRN cash_flow (annual, 2026-01-31) — Financing Cash Flow: -7453000.00
CTRN cash_flow (quarterly, 2026-01-31) — Financing Cash Flow: -312000.00
CTRN cash_flow (annual, 2026-01-31) — Free Cash Flow: 624000.00
CTRN cash_flow (quarterly, 2026-01-31) — Free Cash Flow: 14676000.00
CTRN cash_flow (annual, 2026-01-31) — Gain Loss On Sale Of PPE: -602000.00
CTRN cash_flow (quarterly, 2026-01-31) — Gain Loss On Sale Of PPE: 10334000.00
CTRN income_statement (annual, 2026-01-31) — Gain On Sale Of Ppe: 10960000.00
CTRN income_statement (quarterly, 2026-01-31) — Gain On Sale Of Ppe: 0.00
CTRN balance_sheet (annual, 2026-01-31) — Gross PPE: 578080000.00
CTRN balance_sheet (quarterly, 2026-01-31) — Gross PPE: 578080000.00
CTRN income_statement (annual, 2026-01-31) — Gross Profit: 324642000.00
CTRN income_statement (quarterly, 2026-01-31) — Gross Profit: 91930000.00
CTRN income_statement (annual, 2026-01-31) — Impairment Of Capital Assets: 579000.00
CTRN income_statement (annual, 2026-01-31) — Interest Expense: 342000.00
CTRN income_statement (quarterly, 2026-01-31) — Interest Expense: 87000.00
CTRN income_statement (annual, 2026-01-31) — Interest Expense Non Operating: 342000.00
CTRN income_statement (quarterly, 2026-01-31) — Interest Expense Non Operating: 87000.00
CTRN income_statement (annual, 2026-01-31) — Interest Income: 1993000.00
CTRN income_statement (quarterly, 2026-01-31) — Interest Income: 605000.00
CTRN income_statement (annual, 2026-01-31) — Interest Income Non Operating: 1993000.00
CTRN income_statement (quarterly, 2026-01-31) — Interest Income Non Operating: 605000.00
CTRN cash_flow (annual, 2026-01-31) — Interest Paid Supplemental Data: 210000.00
CTRN cash_flow (quarterly, 2026-01-31) — Interest Paid Supplemental Data: 55000.00
CTRN balance_sheet (annual, 2026-01-31) — Inventory: 113515000.00
CTRN balance_sheet (quarterly, 2026-01-31) — Inventory: 113515000.00
CTRN balance_sheet (annual, 2026-01-31) — Invested Capital: 116320000.00
CTRN balance_sheet (quarterly, 2026-01-31) — Invested Capital: 116320000.00
CTRN cash_flow (annual, 2026-01-31) — Investing Cash Flow: -8494000.00
CTRN cash_flow (quarterly, 2026-01-31) — Investing Cash Flow: -4181000.00
CTRN balance_sheet (annual, 2026-01-31) — Leases: 146979000.00
CTRN balance_sheet (quarterly, 2026-01-31) — Leases: 146979000.00
CTRN balance_sheet (annual, 2026-01-31) — Long Term Capital Lease Obligation: 178921000.00
CTRN balance_sheet (quarterly, 2026-01-31) — Long Term Capital Lease Obligation: 178921000.00
CTRN balance_sheet (annual, 2026-01-31) — Long Term Debt And Capital Lease Obligation: 178921000.00
CTRN balance_sheet (quarterly, 2026-01-31) — Long Term Debt And Capital Lease Obligation: 178921000.00
CTRN balance_sheet (annual, 2026-01-31) — Machinery Furniture Equipment: 208470000.00
CTRN balance_sheet (quarterly, 2026-01-31) — Machinery Furniture Equipment: 208470000.00
CTRN cash_flow (annual, 2026-01-31) — Net Common Stock Issuance: -6315000.00
CTRN cash_flow (quarterly, 2026-01-31) — Net Common Stock Issuance: 0.00
CTRN income_statement (annual, 2026-01-31) — Net Income: 5207000.00
CTRN income_statement (quarterly, 2026-01-31) — Net Income: 7412000.00
CTRN income_statement (annual, 2026-01-31) — Net Income Common Stockholders: 5207000.00
CTRN income_statement (quarterly, 2026-01-31) — Net Income Common Stockholders: 7412000.00
CTRN income_statement (annual, 2026-01-31) — Net Income Continuous Operations: 5207000.00
CTRN income_statement (quarterly, 2026-01-31) — Net Income Continuous Operations: 7412000.00
CTRN income_statement (annual, 2026-01-31) — Net Income From Continuing And Discontinued Operation: 5207000.00
CTRN income_statement (quarterly, 2026-01-31) — Net Income From Continuing And Discontinued Operation: 7412000.00
CTRN income_statement (annual, 2026-01-31) — Net Income From Continuing Operation Net Minority Interest: 5207000.00
CTRN income_statement (quarterly, 2026-01-31) — Net Income From Continuing Operation Net Minority Interest: 7412000.00
CTRN cash_flow (annual, 2026-01-31) — Net Income From Continuing Operations: 5207000.00
CTRN cash_flow (quarterly, 2026-01-31) — Net Income From Continuing Operations: 7412000.00
CTRN income_statement (annual, 2026-01-31) — Net Income Including Noncontrolling Interests: 5207000.00
CTRN income_statement (quarterly, 2026-01-31) — Net Income Including Noncontrolling Interests: 7412000.00
CTRN income_statement (annual, 2026-01-31) — Net Interest Income: 1651000.00
CTRN income_statement (quarterly, 2026-01-31) — Net Interest Income: 518000.00
CTRN income_statement (annual, 2026-01-31) — Net Non Operating Interest Income Expense: 1651000.00
CTRN income_statement (quarterly, 2026-01-31) — Net Non Operating Interest Income Expense: 518000.00
CTRN cash_flow (annual, 2026-01-31) — Net Other Financing Charges: -1138000.00
CTRN cash_flow (quarterly, 2026-01-31) — Net Other Financing Charges: -312000.00
CTRN cash_flow (annual, 2026-01-31) — Net Other Investing Changes: 630000.00
CTRN balance_sheet (annual, 2026-01-31) — Net PPE: 276159000.00
CTRN balance_sheet (quarterly, 2026-01-31) — Net PPE: 276159000.00
CTRN cash_flow (annual, 2026-01-31) — Net PPE Purchase And Sale: -9124000.00
CTRN cash_flow (quarterly, 2026-01-31) — Net PPE Purchase And Sale: -4811000.00
CTRN balance_sheet (annual, 2026-01-31) — Net Tangible Assets: 116320000.00
CTRN balance_sheet (quarterly, 2026-01-31) — Net Tangible Assets: 116320000.00
CTRN balance_sheet (annual, 2026-01-31) — Non Current Deferred Liabilities: 245000.00
CTRN balance_sheet (quarterly, 2026-01-31) — Non Current Deferred Liabilities: 245000.00
CTRN balance_sheet (annual, 2026-01-31) — Non Current Deferred Taxes Liabilities: 245000.00
CTRN balance_sheet (quarterly, 2026-01-31) — Non Current Deferred Taxes Liabilities: 245000.00
CTRN income_statement (annual, 2026-01-31) — Normalized EBITDA: 13464000.00
CTRN income_statement (quarterly, 2026-01-31) — Normalized EBITDA: 12502000.00
CTRN income_statement (annual, 2026-01-31) — Normalized Income: -5112850.00
CTRN income_statement (quarterly, 2026-01-31) — Normalized Income: 7190832.38
CTRN cash_flow (annual, 2026-01-31) — Operating Cash Flow: 20954000.00
CTRN cash_flow (quarterly, 2026-01-31) — Operating Cash Flow: 19487000.00
CTRN cash_flow (annual, 2026-01-31) — Operating Gains Losses: -11562000.00
CTRN cash_flow (quarterly, 2026-01-31) — Operating Gains Losses: -626000.00
CTRN income_statement (annual, 2026-01-31) — Operating Income: -7011000.00
CTRN income_statement (quarterly, 2026-01-31) — Operating Income: 6960000.00
CTRN income_statement (annual, 2026-01-31) — Operating Revenue: 819962000.00
CTRN income_statement (quarterly, 2026-01-31) — Operating Revenue: 230393000.00
CTRN balance_sheet (annual, 2026-01-31) — Ordinary Shares Number: 8345917.00
CTRN balance_sheet (quarterly, 2026-01-31) — Ordinary Shares Number: 8345917.00
CTRN balance_sheet (annual, 2026-01-31) — Other Current Assets: 12254000.00
CTRN balance_sheet (quarterly, 2026-01-31) — Other Current Assets: 12254000.00
CTRN income_statement (annual, 2026-01-31) — Other Income Expense: 10863000.00
CTRN income_statement (quarterly, 2026-01-31) — Other Income Expense: 230000.00
CTRN cash_flow (annual, 2026-01-31) — Other Non Cash Items: 47733000.00
CTRN cash_flow (quarterly, 2026-01-31) — Other Non Cash Items: 12046000.00
CTRN balance_sheet (annual, 2026-01-31) — Other Non Current Assets: 1964000.00
CTRN balance_sheet (quarterly, 2026-01-31) — Other Non Current Assets: 1964000.00
CTRN balance_sheet (annual, 2026-01-31) — Other Non Current Liabilities: 2278000.00
CTRN balance_sheet (quarterly, 2026-01-31) — Other Non Current Liabilities: 2278000.00
CTRN balance_sheet (annual, 2026-01-31) — Other Properties: 221775000.00
CTRN balance_sheet (quarterly, 2026-01-31) — Other Properties: 221775000.00
CTRN income_statement (annual, 2026-01-31) — Other Special Charges: -482000.00
CTRN balance_sheet (annual, 2026-01-31) — Payables: 100693000.00
CTRN balance_sheet (quarterly, 2026-01-31) — Payables: 100693000.00
CTRN balance_sheet (annual, 2026-01-31) — Payables And Accrued Expenses: 115827000.00
CTRN balance_sheet (quarterly, 2026-01-31) — Payables And Accrued Expenses: 115827000.00
CTRN balance_sheet (annual, 2026-01-31) — Pensionand Other Post Retirement Benefit Plans Current: 12800000.00
CTRN balance_sheet (quarterly, 2026-01-31) — Pensionand Other Post Retirement Benefit Plans Current: 12800000.00
CTRN income_statement (annual, 2026-01-31) — Pretax Income: 5503000.00
CTRN income_statement (quarterly, 2026-01-31) — Pretax Income: 7708000.00
CTRN balance_sheet (annual, 2026-01-31) — Properties: 0.00
CTRN balance_sheet (quarterly, 2026-01-31) — Properties: 0.00
CTRN cash_flow (annual, 2026-01-31) — Purchase Of PPE: -20330000.00
CTRN cash_flow (quarterly, 2026-01-31) — Purchase Of PPE: -4811000.00
CTRN balance_sheet (annual, 2026-01-31) — Receivables: 1187000.00
CTRN balance_sheet (quarterly, 2026-01-31) — Receivables: 1187000.00
CTRN income_statement (annual, 2026-01-31) — Reconciled Cost Of Revenue: 495320000.00
CTRN income_statement (quarterly, 2026-01-31) — Reconciled Cost Of Revenue: 138463000.00
CTRN income_statement (annual, 2026-01-31) — Reconciled Depreciation: 18482000.00
CTRN income_statement (quarterly, 2026-01-31) — Reconciled Depreciation: 4937000.00
CTRN cash_flow (annual, 2026-01-31) — Repurchase Of Capital Stock: -6315000.00
CTRN cash_flow (quarterly, 2026-01-31) — Repurchase Of Capital Stock: 0.00
CTRN balance_sheet (annual, 2026-01-31) — Retained Earnings: 281108000.00
CTRN balance_sheet (quarterly, 2026-01-31) — Retained Earnings: 281108000.00
CTRN cash_flow (annual, 2026-01-31) — Sale Of PPE: 11206000.00
CTRN cash_flow (quarterly, 2026-01-31) — Sale Of PPE: 0.00
CTRN income_statement (annual, 2026-01-31) — Selling General And Administration: 313171000.00
CTRN income_statement (quarterly, 2026-01-31) — Selling General And Administration: 80033000.00
CTRN balance_sheet (annual, 2026-01-31) — Share Issued: 16545723.00
CTRN balance_sheet (quarterly, 2026-01-31) — Share Issued: 16545723.00
CTRN income_statement (annual, 2026-01-31) — Special Income Charges: 10863000.00
CTRN income_statement (quarterly, 2026-01-31) — Special Income Charges: 230000.00
CTRN cash_flow (annual, 2026-01-31) — Stock Based Compensation: 5389000.00
CTRN cash_flow (quarterly, 2026-01-31) — Stock Based Compensation: 1388000.00
CTRN balance_sheet (annual, 2026-01-31) — Stockholders Equity: 116320000.00
CTRN balance_sheet (quarterly, 2026-01-31) — Stockholders Equity: 116320000.00
CTRN balance_sheet (annual, 2026-01-31) — Tangible Book Value: 116320000.00
CTRN balance_sheet (quarterly, 2026-01-31) — Tangible Book Value: 116320000.00
CTRN income_statement (annual, 2026-01-31) — Tax Effect Of Unusual Items: 543150.00
CTRN income_statement (quarterly, 2026-01-31) — Tax Effect Of Unusual Items: 8832.38
CTRN income_statement (annual, 2026-01-31) — Tax Provision: 296000.00
CTRN income_statement (quarterly, 2026-01-31) — Tax Provision: 296000.00
CTRN income_statement (annual, 2026-01-31) — Tax Rate For Calcs: 0.05
CTRN income_statement (quarterly, 2026-01-31) — Tax Rate For Calcs: 0.04
CTRN balance_sheet (annual, 2026-01-31) — Taxes Receivable: 1187000.00
CTRN balance_sheet (quarterly, 2026-01-31) — Taxes Receivable: 1187000.00
CTRN balance_sheet (annual, 2026-01-31) — Total Assets: 471171000.00
CTRN balance_sheet (quarterly, 2026-01-31) — Total Assets: 471171000.00
CTRN balance_sheet (annual, 2026-01-31) — Total Capitalization: 116320000.00
CTRN balance_sheet (quarterly, 2026-01-31) — Total Capitalization: 116320000.00
CTRN balance_sheet (annual, 2026-01-31) — Total Debt: 223318000.00
CTRN balance_sheet (quarterly, 2026-01-31) — Total Debt: 223318000.00
CTRN balance_sheet (annual, 2026-01-31) — Total Equity Gross Minority Interest: 116320000.00
CTRN balance_sheet (quarterly, 2026-01-31) — Total Equity Gross Minority Interest: 116320000.00
CTRN income_statement (annual, 2026-01-31) — Total Expenses: 826973000.00
CTRN income_statement (quarterly, 2026-01-31) — Total Expenses: 223433000.00
CTRN balance_sheet (annual, 2026-01-31) — Total Liabilities Net Minority Interest: 354851000.00
CTRN balance_sheet (quarterly, 2026-01-31) — Total Liabilities Net Minority Interest: 354851000.00
CTRN balance_sheet (annual, 2026-01-31) — Total Non Current Assets: 278123000.00
CTRN balance_sheet (quarterly, 2026-01-31) — Total Non Current Assets: 278123000.00
CTRN balance_sheet (annual, 2026-01-31) — Total Non Current Liabilities Net Minority Interest: 181444000.00
CTRN balance_sheet (quarterly, 2026-01-31) — Total Non Current Liabilities Net Minority Interest: 181444000.00
CTRN income_statement (annual, 2026-01-31) — Total Operating Income As Reported: 3852000.00
CTRN income_statement (quarterly, 2026-01-31) — Total Operating Income As Reported: 7190000.00
CTRN income_statement (annual, 2026-01-31) — Total Unusual Items: 10863000.00
CTRN income_statement (quarterly, 2026-01-31) — Total Unusual Items: 230000.00
CTRN income_statement (annual, 2026-01-31) — Total Unusual Items Excluding Goodwill: 10863000.00
CTRN income_statement (quarterly, 2026-01-31) — Total Unusual Items Excluding Goodwill: 230000.00
CTRN balance_sheet (annual, 2026-01-31) — Treasury Shares Number: 8199806.00
CTRN balance_sheet (quarterly, 2026-01-31) — Treasury Shares Number: 8199806.00
CTRN balance_sheet (annual, 2026-01-31) — Treasury Stock: 277303000.00
CTRN balance_sheet (quarterly, 2026-01-31) — Treasury Stock: 277303000.00
CTRN balance_sheet (annual, 2026-01-31) — Working Capital: 19641000.00
CTRN balance_sheet (quarterly, 2026-01-31) — Working Capital: 19641000.00
CTRN income_statement (quarterly, 2026-04-30) — +Operating Expense: 84853000.00
CTRN income_statement (quarterly, 2026-04-30) — +Total Revenue: 230858000.00
CTRN balance_sheet (quarterly, 2026-04-30) — Accounts Payable: 113238000.00
CTRN balance_sheet (quarterly, 2026-04-30) — Accumulated Depreciation: -306694000.00
CTRN balance_sheet (quarterly, 2026-04-30) — Additional Paid In Capital: 113621000.00
CTRN cash_flow (quarterly, 2026-04-30) — Asset Impairment Charge: 0.00
CTRN income_statement (quarterly, 2026-04-30) — Basic Average Shares: 8126000.00
CTRN income_statement (quarterly, 2026-04-30) — Basic EPS: 0.95
CTRN cash_flow (quarterly, 2026-04-30) — Beginning Cash Position: 66092000.00
CTRN cash_flow (quarterly, 2026-04-30) — Capital Expenditure: -5833000.00
CTRN balance_sheet (quarterly, 2026-04-30) — Capital Lease Obligations: 226462000.00
CTRN balance_sheet (quarterly, 2026-04-30) — Capital Stock: 163000.00
CTRN balance_sheet (quarterly, 2026-04-30) — Cash And Cash Equivalents: 81100000.00
CTRN balance_sheet (quarterly, 2026-04-30) — Cash Cash Equivalents And Short Term Investments: 81100000.00
CTRN cash_flow (quarterly, 2026-04-30) — Cash Flow From Continuing Financing Activities: -34000.00
CTRN cash_flow (quarterly, 2026-04-30) — Cash Flow From Continuing Investing Activities: -5833000.00
CTRN cash_flow (quarterly, 2026-04-30) — Cash Flow From Continuing Operating Activities: 20875000.00
CTRN cash_flow (quarterly, 2026-04-30) — Change In Account Payable: 12572000.00
CTRN cash_flow (quarterly, 2026-04-30) — Change In Accrued Expense: -13887000.00
CTRN cash_flow (quarterly, 2026-04-30) — Change In Inventory: -1731000.00
CTRN cash_flow (quarterly, 2026-04-30) — Change In Other Current Assets: 140000.00
CTRN cash_flow (quarterly, 2026-04-30) — Change In Other Working Capital: 665000.00
CTRN cash_flow (quarterly, 2026-04-30) — Change In Payable: 12572000.00
CTRN cash_flow (quarterly, 2026-04-30) — Change In Payables And Accrued Expense: -1315000.00
CTRN cash_flow (quarterly, 2026-04-30) — Change In Prepaid Assets: -3170000.00
CTRN cash_flow (quarterly, 2026-04-30) — Change In Working Capital: -5411000.00
CTRN cash_flow (quarterly, 2026-04-30) — Changes In Cash: 15008000.00
CTRN balance_sheet (quarterly, 2026-04-30) — Common Stock: 163000.00
CTRN balance_sheet (quarterly, 2026-04-30) — Common Stock Equity: 125343000.00
CTRN cash_flow (quarterly, 2026-04-30) — Common Stock Payments: 0.00
CTRN income_statement (quarterly, 2026-04-30) — Cost Of Revenue: 138630000.00
CTRN balance_sheet (quarterly, 2026-04-30) — Current Accrued Expenses: 17430000.00
CTRN balance_sheet (quarterly, 2026-04-30) — Current Assets: 212958000.00
CTRN balance_sheet (quarterly, 2026-04-30) — Current Capital Lease Obligation: 44046000.00
CTRN balance_sheet (quarterly, 2026-04-30) — Current Debt And Capital Lease Obligation: 44046000.00
CTRN balance_sheet (quarterly, 2026-04-30) — Current Deferred Liabilities: 1049000.00
CTRN balance_sheet (quarterly, 2026-04-30) — Current Deferred Revenue: 1049000.00
CTRN balance_sheet (quarterly, 2026-04-30) — Current Liabilities: 185979000.00
CTRN cash_flow (quarterly, 2026-04-30) — Depreciation: 5108000.00
CTRN cash_flow (quarterly, 2026-04-30) — Depreciation Amortization Depletion: 5108000.00
CTRN income_statement (quarterly, 2026-04-30) — Depreciation Amortization Depletion Income Statement: 5108000.00
CTRN cash_flow (quarterly, 2026-04-30) — Depreciation And Amortization: 5108000.00
CTRN income_statement (quarterly, 2026-04-30) — Depreciation And Amortization In Income Statement: 5108000.00
CTRN income_statement (quarterly, 2026-04-30) — Depreciation Income Statement: 5108000.00
CTRN income_statement (quarterly, 2026-04-30) — Diluted Average Shares: 8484000.00
CTRN income_statement (quarterly, 2026-04-30) — Diluted EPS: 0.91
CTRN income_statement (quarterly, 2026-04-30) — Diluted NI Availto Com Stockholders: 7754000.00
CTRN income_statement (quarterly, 2026-04-30) — EBIT: 8022000.00
CTRN income_statement (quarterly, 2026-04-30) — EBITDA: 13130000.00
CTRN cash_flow (quarterly, 2026-04-30) — End Cash Position: 81100000.00
CTRN cash_flow (quarterly, 2026-04-30) — Financing Cash Flow: -34000.00
CTRN cash_flow (quarterly, 2026-04-30) — Free Cash Flow: 15042000.00
CTRN cash_flow (quarterly, 2026-04-30) — Gain Loss On Sale Of PPE: 1000.00
CTRN balance_sheet (quarterly, 2026-04-30) — Gross PPE: 588103000.00
CTRN income_statement (quarterly, 2026-04-30) — Gross Profit: 92228000.00
CTRN income_statement (quarterly, 2026-04-30) — Interest Expense: 86000.00
CTRN income_statement (quarterly, 2026-04-30) — Interest Expense Non Operating: 86000.00
CTRN income_statement (quarterly, 2026-04-30) — Interest Income: 647000.00
CTRN income_statement (quarterly, 2026-04-30) — Interest Income Non Operating: 647000.00
CTRN cash_flow (quarterly, 2026-04-30) — Interest Paid Supplemental Data: 64000.00
CTRN balance_sheet (quarterly, 2026-04-30) — Inventory: 115246000.00
CTRN balance_sheet (quarterly, 2026-04-30) — Invested Capital: 125343000.00
CTRN cash_flow (quarterly, 2026-04-30) — Investing Cash Flow: -5833000.00
CTRN balance_sheet (quarterly, 2026-04-30) — Long Term Capital Lease Obligation: 182416000.00
CTRN balance_sheet (quarterly, 2026-04-30) — Long Term Debt And Capital Lease Obligation: 182416000.00
CTRN cash_flow (quarterly, 2026-04-30) — Net Common Stock Issuance: 0.00
CTRN income_statement (quarterly, 2026-04-30) — Net Income: 7754000.00
CTRN income_statement (quarterly, 2026-04-30) — Net Income Common Stockholders: 7754000.00
CTRN income_statement (quarterly, 2026-04-30) — Net Income Continuous Operations: 7754000.00
CTRN income_statement (quarterly, 2026-04-30) — Net Income From Continuing And Discontinued Operation: 7754000.00
CTRN income_statement (quarterly, 2026-04-30) — Net Income From Continuing Operation Net Minority Interest: 7754000.00
CTRN cash_flow (quarterly, 2026-04-30) — Net Income From Continuing Operations: 7754000.00
CTRN income_statement (quarterly, 2026-04-30) — Net Income Including Noncontrolling Interests: 7754000.00
CTRN income_statement (quarterly, 2026-04-30) — Net Interest Income: 561000.00
CTRN income_statement (quarterly, 2026-04-30) — Net Non Operating Interest Income Expense: 561000.00
CTRN cash_flow (quarterly, 2026-04-30) — Net Other Financing Charges: -34000.00
CTRN balance_sheet (quarterly, 2026-04-30) — Net PPE: 281409000.00
CTRN cash_flow (quarterly, 2026-04-30) — Net PPE Purchase And Sale: -5833000.00
CTRN balance_sheet (quarterly, 2026-04-30) — Net Tangible Assets: 125343000.00
CTRN balance_sheet (quarterly, 2026-04-30) — Non Current Deferred Liabilities: 244000.00
CTRN balance_sheet (quarterly, 2026-04-30) — Non Current Deferred Taxes Liabilities: 244000.00
CTRN income_statement (quarterly, 2026-04-30) — Normalized EBITDA: 13130000.00
CTRN income_statement (quarterly, 2026-04-30) — Normalized Income: 7754000.00
CTRN cash_flow (quarterly, 2026-04-30) — Operating Cash Flow: 20875000.00
CTRN cash_flow (quarterly, 2026-04-30) — Operating Gains Losses: 1000.00
CTRN income_statement (quarterly, 2026-04-30) — Operating Income: 7375000.00
CTRN income_statement (quarterly, 2026-04-30) — Operating Revenue: 230858000.00
CTRN balance_sheet (quarterly, 2026-04-30) — Ordinary Shares Number: 8356768.00
CTRN balance_sheet (quarterly, 2026-04-30) — Other Current Assets: 16090000.00
CTRN cash_flow (quarterly, 2026-04-30) — Other Non Cash Items: 12120000.00
CTRN balance_sheet (quarterly, 2026-04-30) — Other Non Current Assets: 1824000.00
CTRN balance_sheet (quarterly, 2026-04-30) — Other Non Current Liabilities: 2209000.00
CTRN balance_sheet (quarterly, 2026-04-30) — Other Properties: 588103000.00
CTRN balance_sheet (quarterly, 2026-04-30) — Payables: 113238000.00
CTRN balance_sheet (quarterly, 2026-04-30) — Payables And Accrued Expenses: 130668000.00
CTRN balance_sheet (quarterly, 2026-04-30) — Pensionand Other Post Retirement Benefit Plans Current: 10216000.00
CTRN income_statement (quarterly, 2026-04-30) — Pretax Income: 7936000.00
CTRN cash_flow (quarterly, 2026-04-30) — Purchase Of PPE: -5833000.00
CTRN balance_sheet (quarterly, 2026-04-30) — Receivables: 522000.00
CTRN income_statement (quarterly, 2026-04-30) — Reconciled Cost Of Revenue: 138630000.00
CTRN income_statement (quarterly, 2026-04-30) — Reconciled Depreciation: 5108000.00
CTRN cash_flow (quarterly, 2026-04-30) — Repurchase Of Capital Stock: 0.00
CTRN balance_sheet (quarterly, 2026-04-30) — Retained Earnings: 288862000.00
CTRN income_statement (quarterly, 2026-04-30) — Selling General And Administration: 79745000.00
CTRN balance_sheet (quarterly, 2026-04-30) — Share Issued: 16556574.00
CTRN income_statement (quarterly, 2026-04-30) — Special Income Charges: 0.00
CTRN cash_flow (quarterly, 2026-04-30) — Stock Based Compensation: 1303000.00
CTRN balance_sheet (quarterly, 2026-04-30) — Stockholders Equity: 125343000.00
CTRN balance_sheet (quarterly, 2026-04-30) — Tangible Book Value: 125343000.00
CTRN income_statement (quarterly, 2026-04-30) — Tax Effect Of Unusual Items: 0.00
CTRN income_statement (quarterly, 2026-04-30) — Tax Provision: 182000.00
CTRN income_statement (quarterly, 2026-04-30) — Tax Rate For Calcs: 0.02
CTRN balance_sheet (quarterly, 2026-04-30) — Taxes Receivable: 522000.00
CTRN balance_sheet (quarterly, 2026-04-30) — Total Assets: 496191000.00
CTRN balance_sheet (quarterly, 2026-04-30) — Total Capitalization: 125343000.00
CTRN balance_sheet (quarterly, 2026-04-30) — Total Debt: 226462000.00
CTRN balance_sheet (quarterly, 2026-04-30) — Total Equity Gross Minority Interest: 125343000.00
CTRN income_statement (quarterly, 2026-04-30) — Total Expenses: 223483000.00
CTRN balance_sheet (quarterly, 2026-04-30) — Total Liabilities Net Minority Interest: 370848000.00
CTRN balance_sheet (quarterly, 2026-04-30) — Total Non Current Assets: 283233000.00
CTRN balance_sheet (quarterly, 2026-04-30) — Total Non Current Liabilities Net Minority Interest: 184869000.00
CTRN income_statement (quarterly, 2026-04-30) — Total Operating Income As Reported: 7375000.00
CTRN income_statement (quarterly, 2026-04-30) — Total Unusual Items: 0.00
CTRN income_statement (quarterly, 2026-04-30) — Total Unusual Items Excluding Goodwill: 0.00
CTRN balance_sheet (quarterly, 2026-04-30) — Treasury Shares Number: 8199806.00
CTRN balance_sheet (quarterly, 2026-04-30) — Treasury Stock: 277303000.00
CTRN balance_sheet (quarterly, 2026-04-30) — Working Capital: 26979000.00
CTRN income_statement (quarterly, 2026-04-30) — Write Off: 0.00
CTS cash_flow (annual, 2021-12-31) — Asset Impairment Charge: 0.00
CTS balance_sheet (annual, 2021-12-31) — Defined Pension Benefit: 49382000.00
CTS cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of PPE: 0.00
CTS income_statement (annual, 2021-12-31) — Gain On Sale Of Ppe: 0.00
CTS cash_flow (annual, 2021-12-31) — Net Foreign Currency Exchange Gain Loss: -35000.00
CTS income_statement (annual, 2022-12-31) — +Operating Expense: 115620000.00
CTS income_statement (annual, 2022-12-31) — +Total Revenue: 586869000.00